Logo
Menu

Delivering a complete colorectal cancer solution for you and your patients

Trust the experts with over 20 years of experience. 

Tests & services
Tests & services

Colorectal cancer is the fourth most common type of cancer in the United States.1
One in 24 people will be diagnosed with colorectal cancer in their lifetime.2

The NeoGenomics colorectal cancer solution supports the care continuum with tests that detect genomic alterations relevant to diagnosis, therapy selection, prognosis, and clinical trial options.

Featured colorectal cancer solutions

Neo Comprehensive - Solid Tumor

NGS comprehensive genomic profile targeting 517 genes in DNA and RNA for SNVs, InDels, CNVs, RNA fusions/splice variants with MSI and TMB for pan-solid tumors.

8-10 Days turnaround time

Learn more about this test

Comprehensive testing for colorectal cancer patients

Biomarker testing can help providers streamline their approach to treatment decisions, and adherence to guideline-recommended biomarker testing may help improve patient outcomes in general and reduce exposure to expensive therapies that are likely to be ineffective for the patient’s molecular subtype. Next-generation sequencing (NGS) panels have the advantage of being able to detect rare and clinically actionable alterations, as well as targets that may be important in the future (ie, emerging biomarkers) or that are being studied in clinical trials. The NeoGenomics colorectal cancer solution provides the answers you need for therapy selection by utilizing comprehensive genomic profiling (CGP).

Clinically actionable biomarkers for colorectal cancer3,4

colorectal biomarkers

MSI, microsatellite instability.

Add-on testing for therapy selection

Mismatch Repair (MMR) IHC Panel

Global: 2 Days, Image Analysis (Tech-only): 2 Days, Tech-Only (stain only): 1 Day turnaround time

Learn more about this test

HER2 (Other)

Global: 2 Day, Tech-Only (stain only): 1 Day turnaround time

Learn more about this test

References

  1. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program. Cancer stat facts: colorectal cancer. Accessed December 23, 2024. https://seer.cancer.gov/statfacts/html/colorect.html

  2. Colorectal Cancer Alliance. Colorectal cancer facts and statistics. Accessed December 23, 2024.
    https://colorectalcancer.org/basics/facts-and-statistics

  3. Suehnholz SP, Nissan MH, Zhang H, et al. Quantifying the expanding landscape of clinical actionability for patients with cancer. Cancer Discov. 2024;14(1):49-65.

  4. Chakravarty D, Gao J, Phillips S, et al. OncoKB: A precision oncology knowledge base. JCO Precis Oncol. 2017;2017:PO.17.00011.

Still have questions?

We pride ourselves on our unparalleled Client Services team. If you have questions regarding test information, specimen requirements, turnaround times, test add-ons, or patient results, please email us at client.services@neogenomics.com or call 866.776.5907, Option 3.